Procter & Gamble Hygiene and Health Care Ltd announced its financial results for the quarter ended December 31, 2021. The company delivered sales of Rs 1093 crores, up 7% vs year-ago behind the strength of its trusted product portfolio and strong retail execution. Profit After Tax (PAT) was Rs 212 crores, down 15% vs year ago due to lower advertising and promotion investments on brand building in the base period due to the pandemic and commodity cost inflation. For the quarter, both Feminine Care and Health Care businesses grew ahead of their categories. Compared to the corresponding quarter two years ago, prior to the pandemic, company sales are up 27% and profit is up 56%.
Madhusudan Gopalan, Managing Director, Procter & Gamble Hygiene and Health Care Ltd. said, “In a challenging market environment, we have delivered strong sales growth behind strong brand fundamentals and improved market execution. As the industry faces commodity inflation challenges, we continue to focus on improving productivity by leveraging advertising and promotion analytics, strengthening our product mix and driving supply chain efficiency to drive balanced top and bottom-line growth. We will continue to focus on our strategy of driving superiority and productivity, invest in brand building, enabled by the strength of our organization and culture.”
The company’s feminine care brand Whisper continues to step up to raise awareness about menstrual hygiene education. Through its ‘Whisper Menstrual Health & Hygiene Program’, the brand educates more than 90 lakh girls annually on menstrual hygiene. Whisper has also committed to educating 2.5 crore+ adolescent girls on puberty and hygiene over the next three years. In addition, through its ‘Period of Pride’ campaign, Whisper is advocating for menstrual hygiene to be a part of the school curriculum. Whisper is developing this module in partnership with UNESCO and more than 10 lakh people have signed the petition for this endeavor. As part of the company’s COVID-19 relief and response program #PGSurakshaIndia program, the company continues to extend its support to communities through the donation of in-house manufactured masks and sanitizers to combat the spread of COVID-19. The Board of Directors declared an interim dividend of ₹ 95 on every equity share of ₹10. The record date for the dividend will be February 9, 2022
